Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel and aspirin versus either agent alone on brachial flow-mediated dilation in stable coronary artery disease
ISRCTN34097747Phase 4Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel and aspirin in coronary arteriosclerosis (3 arms), sponsored by Johannes Gutenberg University Mainz. Primary endpoint: Absolute change in brachial artery flow-mediated dilation. Started Apr 2006; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN34097747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34097747.